openPR Logo
Press release

Euro Biom Launches as UK MHRA-Licensed Pharmaceutical Wholesale Exporter for GCC and Africa

03-31-2026 10:08 AM CET | Health & Medicine

Press release from: Euro Biom Ltd

Euro Biom Ltd - MHRA-Licensed Pharmaceutical Wholesale Exporter

Euro Biom Ltd - MHRA-Licensed Pharmaceutical Wholesale Exporter

London-based distributor brings licensed UK-sourced medicines to healthcare systems across 40+ countries, backed by full MHRA WDA and GDP compliance.

Euro Biom has launched as a UK pharmaceutical wholesale distributor, supplying licensed medicines sourced from the UK to healthcare institutions across the GCC, Africa, Europe, CIS, and Asia.

Headquartered in Harmondsworth, London -- in close proximity to Heathrow Airport -- the company holds an MHRA Wholesale Dealer Authorisation (WDA) and operates under GDP (Good Distribution Practice) guidelines. Euro Biom exports to hospitals, government health ministries, NGOs, and private healthcare groups across more than 40 countries.

The company specialises in non-routine and complex pharmaceutical procurement, including unlicensed medicines supplied under named patient frameworks, shortage medicines where conventional supply chains have failed, specialist biologics and monoclonal antibodies, and hard-to-source branded and generic products across all major therapeutic areas.

Euro Biom's product portfolio spans 21 therapeutic areas including Cardiovascular, Oncology, Diabetes and Endocrinology, Antibiotics and Antimicrobials, Respiratory, CNS and Neurology, Immunology and Transplant, HIV, Haematology, and more -- covering over 5,800 pharmaceutical lines. All products are sourced from verified UK and European manufacturers and distributed under full chain of custody documentation with batch traceability from source to destination.

Compliance documents including WDA certificates and GDP records are available on request for supplier due diligence. Healthcare institutions and procurement teams can submit enquiries at https://www.eurobiom.co.uk

The company has built particular expertise in shortage situations and specialist products, offering procurement teams a compliant, fully documented alternative when conventional supply channels fail. Euro Biom in London, Euro Biom provides compliant, documented pharmaceutical supply for urgent, complex, and non-routine requirements. Company No. 15380737, registered in England and Wales.m's location adjacent to Heathrow -- one of the world's busiest air freight hubs -- enables same-day dispatch for urgent requirements and next-flight-out capability for critical medicines.

According to Shikhar Bhatt, Head of Operations at Euro Biom: "Access to quality medicines should not be determined by geography. Our MHRA authorization and proximity to Heathrow allow us to connect the UK pharmaceutical supply chain with healthcare buyers in markets where reliable, compliant supply is most needed."

Euro Biom serves a growing network of institutional buyers across the GCC and Sub-Saharan Africa, regions where demand for UK-sourced, fully documented pharmaceutical supply has risen significantly due to regulatory requirements, product authenticity concerns, and the complexity of sourcing specialist medicines locally. The company's named patient supply capability is particularly valued by hospitals and government health departments requiring medicines that are not commercially available in their local market.

Euro Biom Ltd
Unit-5 Skyport Drive
Harmondsworth
London UB7 0LJ
United Kingdom

Contact: Shikhar Bhatt, Head of Operations
Phone: +44 7492 670948
Email: work@eurobiom.co.uk
Website: https://www.eurobiom.co.uk

Euro Biom Ltd is a UK-based MHRA-licensed pharmaceutical wholesale distributor holding a Wholesale Dealer Authorisation (WDA). The company specialises in the export of branded, generic, and unlicensed medicines to healthcare institutions, government health ministries, NGOs, and private healthcare groups across 40+ countries in the GCC, Africa, Europe, CIS, and Asia. Operating under GDP (Good Distribution Practice) guidelines from its base near Heathrow Air

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Euro Biom Launches as UK MHRA-Licensed Pharmaceutical Wholesale Exporter for GCC and Africa here

News-ID: 4447761 • Views:

More Releases from Euro Biom Ltd

Euro Biom Publishes Free Import-Documentation Resources for Overseas Hospital Bu …
London, United Kingdom, 21 June 2026 - Euro Biom Ltd, a UK MHRA-licensed pharmaceutical wholesale exporter, has published a set of free, buyer-facing reference resources to help hospital pharmacies, Ministry of Health procurement teams and licensed distributors across the GCC, Africa, Turkey and Asia navigate the documentation required to import UK-licensed medicines. Procurement teams sourcing UK-licensed medicines routinely face a documentation burden that varies sharply from one destination market to the

More Releases for MHRA

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conferenc …
SMi Reports: Industry leaders MHRA, Pfizer, Autolus, Tusk Therapeutics, KCL, Boehringer Ingelheim and more are amongst the latest organisations to register for Immuno-Oncology 2018 (http://www.immuno-oncology-conference.com/openpr) There’s just 2 weeks until SMi’s Immuno-Oncology conference commences in London on the 26th and 27th September. With limited places left, interested attendees are urged to book soon to avoid missing out on joining an international gathering of immuno-therapy experts at this highly-anticipated conference. Recent Confirmed Attendees
Talks from the MHRA, Innovate UK, Plasticell and more
The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising costs in development of novel medicines, as well as the more basic drive to be ‘ahead of the game’, forces the industry and the legislators to rethink basic postulates of drug development. The global regulatory environment is undergoing major reshape, allowing patients early access
MHRA & FDA to explore In Vitro Diagnostics regulations in the EU & USA
The 3rd In Vitro Diagnostics conference for SMi Group will take place in London on the 14th & 15th June 2017. Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape. Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017
Attendee List Released for Superbugs 2017 Featuring FDA, GSK, MHRA, Merck and Ab …
With just 4 weeks to go, an attendee list featuring an international audience of AMR experts and scientific pioneers has been released ahead of SMi's long running 19th annual summit on Superbugs & Superdrugs. The industry calendar highlight on antibiotic resistance will provide a platform for attendee's to network, exchange novel solutions and consolidate current strategy. Notable sessions on the agenda include: 1. Guidance on common governing pitfalls presented by the FDA. 2. Strategies to
MHRA to advise on mHealth app initiative for pharmacovigilance
WEB-RADR Project Lead Phil Tregunno joins speaker lineup for the 9th Social Media in the Pharmaceutical Industry in London SMi has confirmed that Phil Tregunno, the MHRA’s Signal Management Unit Manager and WEB-RADR Project Lead, will be speaking at the 9th Social Media in the Pharmaceutical Industry conference. The event takes place on the 18th and 19th of January 2017 in London. More companies continue to improve initiatives for pharmacovigilance. Recently, the
Pharma Cold Chain Distribution Updates from MHRA, IATA, GSK, Teva, J&J, World Co …
SMi Group reports (2016.11.10– London, UK): World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016. Over the last 24 months, we have witnessed market growth and new logistics hubs established around the globe by forwarders and distributors, in order to service and support a more round-the-clock global network for pharmaceutical product supply. Nonetheless, challenges remain with the increasingly fragile biologics